| Literature DB >> 21464464 |
Laura N McEwen1, Catherine Kim, Susan L Ettner, William H Herman, Andrew J Karter, Gloria L Beckles, Arleen F Brown.
Abstract
OBJECTIVE: To determine whether competing demands for time affect diabetes self-care behaviors, processes of care, and intermediate outcomes. RESEARCH DESIGN AND METHODS: We used survey and medical record data from 5,478 participants in Translating Research Into Action for Diabetes (TRIAD) and hierarchical regression models to examine the cross-sectional associations between competing demands for time and diabetes outcomes, including self-management, processes of care, and intermediate health outcomes.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21464464 PMCID: PMC3114509 DOI: 10.2337/dc10-2038
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112
Multivariate linear and logistic regression models stratified by sex (N = 5,478)
| Competing demands/independent variables | ||||
|---|---|---|---|---|
| Neither caregiving nor employment responsibilities (Reference) | Caregiving only | Employment responsibilities only | Both caregiving and employment responsibilities | |
| Women ( | ||||
| Self-care behaviors | ||||
| Physical activity (vigorous vs. none/little) | 0.43 (0.41–0.45) | 0.48 (0.42–0.54) | 0.44 (0.40–0.48) | 0.47 (0.37–0.57) |
| Foot self-care performed | 0.65 (0.63–0.67) | 0.63 (0.57–0.69) | 0.61 (0.57–0.65) | 0.60 (0.50–0.70) |
| Self-monitoring blood glucose (does not adjust for treatment) | ||||
| Oral medication only | 0.47 (0.45–0.49) | 0.50 (0.42–0.58) | 0.43 (0.37–0.49) | 0.46 (0.34–0.58) |
| Insulin users | 0.72 (0.70–0.74) | 0.75 (0.63–0.87) | 0.65 (0.57–0.73) | 0.57 (0.41–0.73) |
| Processes of care | ||||
| Aspirin advised/taking | 0.63 (0.61–0.65) | 0.63 (0.57–0.69) | 0.59 (0.55–0.69) | 0.53 (0.45–0.61) |
| Dilated eye exam performed | 0.80 (0.78–0.82) | 0.78 (0.72–0.84) | 0.79 (0.75–0.83) | 0.75 (0.67–0.83) |
| Foot exam performed | 0.85 (0.83–0.87) | 0.87 (0.81–0.93) | 0.84 (0.80–0.88) | 0.83 (0.77–0.89) |
| Glycemic control assessed | 0.86 (0.84–0.88) | 0.85 (0.79–0.91) | 0.82 (0.78–0.86) | 0.84 (0.76–0.92) |
| Influenza immunization | 0.72 (0.70–0.74) | 0.70 (0.64–0.76) | 0.66 (0.62–0.70) | 0.65 (0.57–0.73) |
| LDL assessed | 0.74 (0.72–0.76) | 0.70 (0.64–0.76) | 0.71 (0.67–0.75) | 0.70 (0.62–0.78) |
| Proteinuria assessed | 0.82 (0.80–0.84) | 0.78 (0.72–0.84) | 0.82 (0.78–0.86) | 0.78 (0.70–0.86) |
| Unweighted sum of seven processes of care | 5.41 (5.35–5.47) | 5.32 (5.12–5.52) | 5.24 (5.12–5.36) | 5.10 (4.85–5.35) |
| Intermediate outcomes | ||||
| HbA1c | 7.86 (7.80–7.92) | 8.17 (7.92–8.42) | 7.96 (7.82–8.10) | 8.16 (7.85–8.47) |
| Systolic blood pressure | 136 (135–137) | 136 (133–139) | 136 (134–138) | 137 (134–140) |
| LDL | 112 (111–113) | 112 (107–117) | 114 (111–117) | 113 (107–119) |
| Men ( | ||||
| Self-care behaviors | ||||
| Physical activity (vigorous vs. none/little) | 0.49 (0.47–0.51) | 0.54 (0.44–0.64) | 0.47 (0.43–0.51) | 0.47 (0.37–0.57) |
| Foot self-care performed | 0.58 (0.56–0.60) | 0.61 (0.49–0.73) | 0.53 (0.49–0.57) | 0.50 (0.40–0.60) |
| Self-monitoring blood glucose (does not adjust for treatment) | ||||
| Oral medication only | 0.38 (0.36–0.40) | 0.39 (0.27–0.51) | 0.33 (0.29–0.37) | 0.31 (0.21–0.41) |
| Insulin users | 0.69 (0.65–0.73) | 0.73 (0.59–0.87) | 0.67 (0.59–0.75) | 0.68 (0.52–0.84) |
| Processes of care | ||||
| Aspirin advised/taking | 0.67 (0.62–0.78) | 0.70 (0.62–0.78) | 0.65 (0.61–0.69) | 0.60 (0.50–0.70) |
| Dilated eye exam performed | 0.77 (0.75–0.79) | 0.73 (0.63–0.83) | 0.75 (0.71–0.79) | 0.73 (0.65–0.81) |
| Foot exam performed | 0.85 (0.83–0.87) | 0.83 (0.75–0.91) | 0.83 (0.79–0.87) | 0.85 (0.77–0.93) |
| Glycemic control assessed | 0.86 (0.84–0.88) | 0.86 (0.80–0.92) | 0.85 (0.81–0.89) | 0.82 (0.74–0.90) |
| Influenza immunization | 0.71 (0.69–0.73) | 0.65 (0.57–0.73) | 0.65 (0.61–0.69) | 0.59 (0.5 –0.67) |
| LDL assessed | 0.76 (0.74–0.78) | 0.77 (0.69–0.85) | 0.74 (0.70–0.78) | 0.70 (0.60–0.80) |
| Proteinuria assessed | 0.82 (0.80–0.84) | 0.82 (0.74–0.90) | 0.80 (0.76–0.84) | 0.79 (0.71–0.87) |
| Unweighted sum of seven processes of care | 5.44 (5.38–5.50) | 5.37 (5.10–5.64) | 5.27 (5.15–5.39) | 5.09 (4.82–5.36) |
| Intermediate outcomes | ||||
| HbA1c | 7.81 (7.73–7.89) | 8.16 (7.85–8.47) | 7.98 (7.84–8.12) | 8.32 (7.97–8.67) |
| Systolic blood pressure | 134 (133–135) | 133 (130–136) | 133 (131–135) | 132 (128–136) |
| LDL | 106 (105–107) | 104 (97–111) | 108 (105–110) | 110 (104–116) |
Predicted probabilities and 95% CIs are shown.
*Adjusted for age, race/ethnicity, education, income, time since diabetes diagnosis, diabetes treatment, health status, spouse employment, spouse education, and provider group.
†P value < 0.05.